STIM Profile
Neuronetics, Inc. is a commercial-stage medical technology company specializing in innovative solutions for neurohealth disorders. The company designs, develops, and markets advanced medical devices with a focus on treating patients with major depressive disorder (MDD). Neuronetics is best known for its flagship product, the NeuroStar Advanced Therapy System, which provides a non-invasive, office-based treatment option for MDD.
The NeuroStar Advanced Therapy System utilizes transcranial magnetic stimulation (TMS) to deliver a pulsed, MRI-strength magnetic field to the brain. This magnetic field generates electrical currents aimed at stimulating targeted areas of the brain that are associated with mood regulation. The therapy is designed to enhance neural activity in these areas, potentially leading to improvements in mood and reductions in depressive symptoms.
Neuronetics’ approach to treatment is distinguished by its non-systemic nature, meaning that it does not involve pharmaceuticals and is free from the systemic side effects commonly associated with medication. The company’s products are marketed and sold through a dedicated sales and customer support team, primarily targeting psychiatrists and mental health professionals who are equipped to offer this advanced therapy to their patients.
Founded in 2001 and headquartered in Malvern, Pennsylvania, Neuronetics has positioned itself at the forefront of neurohealth innovation. The company’s commitment to developing and advancing non-invasive treatment options reflects its dedication to improving patient outcomes in the field of mental health. Its focus on TMS technology underscores its role in offering effective, alternative therapies for individuals suffering from major depressive disorder.
|
